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Abstract Studies of HeLa cells and serum- and glucocor-
ticoid-regulated kinase 1 (SGK1) knockout mice identified
threonine residues in the n-myc downstream-regulated gene
1 protein (NDRG1-Thr346/356/366) that are phosphorylated
by SGK1 but not by related kinases (Murray et al.,
Biochem J 385:1–12, 2005). We have, therefore, monitored
the phosphorylation of NDRG1-Thr346/356/366 in order to
explore the changes in SGK1 activity associated with the
induction and regulation of the glucocorticoid-dependent
Na+ conductance (GNa) in human airway epithelial cells.
Transient expression of active (SGK1-S422D) and inactive
(SGK1-K127A) SGK1 mutants confirmed that activating
SGK1 stimulates NDRG1-Thr346/356/366 phosphorylation.
Although GNa is negligible in hormone-deprived cells,
these cells displayed basal SGK1 activity that was sensitive
to LY294002, an inhibitor of 3-phosphatidylinositol phos-
phate kinase (PI3K). Dexamethasone (0.2 μM) acutely
activated SGK1 and the peak of this response (2–3 h)
coincided with the induction of GNa, and both responses
were PI3K-dependent. While these data suggest that SGK1
might mediate the rise in GNa, transient expression of the
inactive SGK1-K127A mutant did not affect the hormonal
induction of GNa but did suppress the activation of SGK1.
Dexamethasone-treated cells grown on permeable supports
formed confluent epithelial sheets that generated short
circuit current due to electrogenic Na+ absorption. For-
skolin and insulin both stimulated this current and the
response to insulin, but not forskolin, was LY294002-
sensitive and associated with the activation of SGK1. While
these data suggest that SGK1 is involved in the control of
GNa, its role may be minor, which could explain why sgk1
knockout has different effects upon different tissues.
Keywords Glucocorticoids . Epithelial Na+ channel .
n-myc downstream-regulated gene 1 . Cell signaling
Introduction
Many responses to glucocorticoid and mineralocorticoid
hormones involve the activation of serum- and glucocorti-
coid-regulated kinase 1 (SGK1) and genetic deletion of the
sgk1 gene prevents the aldosterone-mediated increase in
renal Na+ retention that normally occurs when dietary Na+
is reduced [53]. However, in the distal colon, sgk1
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knockout also leads to a paradoxical stimulation of Na+
absorption and does not prevent the increased absorption of
fecal Na+ seen in Na+-restricted animals [39]. It is also clear
that sgk1 deletion does not cause overt lung symptoms
despite the fact that the integrated functioning of the
respiratory tract is dependent upon glucocorticoid-induced
absorption of Na+ from the liquid film that covers the lung/
airway epithelia [3, 9, 30] and so, although SGK1 does
seem to be involved in the control of epithelial Na+
absorption [see, e.g., 5, 6, 17, 26, 44], the way in which
this kinase contributes to this regulated ion transport
process is not fully understood [12, 19, 40, 49, 51].
SGK1 belongs to the AGC subfamily of protein
kinases that also includes protein kinase B (PKB),
ribosomal S6 kinases (RSKs, S6Ks), and the mitogen/
stress-activated kinases. However, SGK1 most closely
resembles PKB and these enzymes can phosphorylate
the same proteins, especially if their activities are
assayed in vitro or using cellular over expression
systems [25, 34]. However, it is also clear that SGK1
and PKB selectively phosphorylate certain proteins in
vivo [31] and the product of n-myc downstream gene 1
(NDRG1) has recently been identified as a physiological
substrate for SGK1 but not PKB, RSK1, or S6K1 [31, 32].
This was initially surprising since the NDRG1 residues
that are phosphorylated by SGK1 (Thr346/356/366) form part
of canonical AGC substrate motifs within a C-terminal
nonapeptide (Arg-Ser-Arg-Ser-His-Thr-Ser-Glu-Gly) that
is repeated three times, and this location predicts phos-
phorylation by other AGC kinases. However, studies of
synthetic peptides identified residues within the non-
apeptide that prevented phosphorylation by PKB and
RSK1 [32] and NDRG1-Thr346/356/366 phosphorylation in
HeLa cells and mouse tissues is strictly dependent upon
the expression of SGK1 [31]. Although SGK1 also
phosphorylates other residues within this protein (Thr228
and Ser330), antibodies that recognize the phosphorylation
of these residues cross-react with the equivalent residues
in the closely related NDRG2 protein (Thr330, Ser332). In
contrast, the SGK1 consensus sequences that include
Thr346/356/366 are found within a repeated nonapeptide
that is not found in NDRG2, NDRG3, or NDRG4.
Antibodies against this nonapeptide thus show almost no
cross-reactivity with other phosphoproteins [31].
Since the phosphorylation of NDRG1-Thr346/356/366 can
be assayed using well-characterized antibodies [31], these
data effectively establish a new way of monitoring cellular
SGK1 activity which could simplify physiological studies
of this enzyme [31]. In the present study, we, therefore, use
this new approach to monitor the changes in SGK1 activity
associated with the induction and hormonal regulation of
the glucocorticoid-dependent Na+ conductance (GNa) in a
human airway epithelial cell line [11, 13].
Materials and methods
Cell culture
H441 cells were routinely cultured in RPMI 1640 medium
supplemented with fetal bovine serum (FBS, 8.5%),
newborn calf serum (NCS, 8.5%), glutamine (2 mM),
transferrin (5 μg mL−1), selenium (5 ng mL−1), and an
antibiotic/antimycotic mixture (Sigma Chemical, Poole,
Dorset, England). For experiments, cells removed from
culture flasks using trypsin/ethylenediaminetetraacetic acid
(EDTA) were plated onto glass cover slips, 10 cm Petri
dishes, or Costar Snapwell (Corning BV, Schipol-Rijk, The
Netherlands) culture membranes [37]. After approximately
24 h incubation in standard medium, the cells were washed
and incubated in medium prepared using FBS (8.5%) that
had been dialyzed to remove hormones/growth factors.
Hormone-deprived cells were maintained in this medium
for 24–36 h before being used in experiments while
hormone-stimulated cells were exposed to dexamethasone
(0.2 μM) as described in the text.
Transient transfection
Cells were transfected (Lipofectamine Transfection
Reagent, Invitrogen, UK) with pGL3 plasmids (Invitrogen;
1–1.5 μg per well) incorporating cDNA sequences encod-
ing modified forms of SGK1. The construct used to
enhance cellular SGK1 activity encoded a glutathione S-
transferase (GST) fusion protein incorporating a truncated
form of SGK1 lacking 60 N terminus amino acid residues
that had been further modified by mutating Ser422 to Asp
(SGK1-S422D). The N-terminal truncation induces a 20-
fold to 250-fold increase in protein expression by prevent-
ing protein degradation while the S422D mutation allows
this truncated protein to be more readily activated by 3-
phosphoinositide-dependent protein kinase 1 (PDK1) [25,
26]. Taken together, these changes confer a constitutively
active phenotype upon this mutant [25]. We also explored
the effects of expressing a construct encoding an analogous
GST/truncated SGK1 protein in which Lys127 had been
mutated to Ala (SGK1-K127A). This disrupts the protein’s
ATP-binding site creating a catalytically inactive form of
the enzyme [25]. Cells used for electrophysiological studies
were cotransfected with a second plasmid (pEGFP, 0.1 μg)
encoding green fluorescent protein (GFP) which allowed
successfully transfected cells to be identified by GFP
fluorescence. Membrane currents were recorded from these
cells after approximately 24–26 h (see below). Nonspecific
effects of the transfection procedure and/or expression of a
heterologous protein were controlled for by recording
currents from cells that had simply been transfected with
the GFP-expressing plasmid. The identity of all cDNA
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constructs was independently confirmed by sequencing at
the DNA Analysis Facility, Ninewells Hospital and Medical
School, University of Dundee.
Western blotting
Protein was extracted from cells on Petri dishes by
scraping/sonication in a lysis buffer containing phosphatase
and protease inhibitors (1% Triton; 50 mM Tris–HCl,
pH 7.5; 1 mM ethylene glycol tetraacetic acid; 1 mM
EDTA; 1 mM Na orthovanadate; 10 mM glycerol phos-
phate; 50 mM NaF; 5 mM Na pyrophosphate; 270 mM
sucrose; 0.1% β-mercaptoethanol; 1 Roche Mini Protease
Inhibitor tablet per 10 mL). Extracted protein was then
diluted (3:1) with 4x NuPage LDS sample buffer (Invi-
trogen), denatured at 70°C (10 min), and aliquots of
denatured protein (normally 12 μg) fractionated on sodium
dodecyl sulfate polyacrylamide gels (NuPage Novex Bis-
Tris Mini gels, Invitrogen) and blotted onto Hybond-P
membranes (Amersham, Buckinghamshire, UK). Total
NDRG-1 abundance was then determined by Western
analysis using an antibody [31] against the full-length
protein, while expression of Thr346/356/366-phosphorylated
NDRG1 was quantified using a phosphospecific antibody
against the SGK1-phosphorylated form of the C-terminal
nonapeptide [31]. Preliminary experiments verified that
these antibodies stained only a single substantive band in
protein extracted from H441 cells. The electrophoretic
mobility of this protein indicated a molecular weight of
45 kDa, which accords well with the previously reported
value of 43–45 kDa [31]. The phosphorylation of cyclic
adenosine monophosphate (cAMP) response element-
binding protein (CREB) at Ser133 was similarly quantified
using antibodies against total and Ser133-phosphorylated
CREB (Upstate, Dundee, UK). Results of such experiments
were quantified by densitometry using the Syngene
Genegenius (Synoptics) image-capturing system, GeneSnap
image-capturing program, and GeneTools densitometry
analysis program.
Single-cell electrophysiology
Membrane currents (Im) were recorded from single cells
held under voltage clamp in the perforated patch recording
configuration using bath and pipette solutions designed to
maintain quasiphysiological ionic gradients [11, 13]. In
each experiment, the mean current evoked by driving the
holding potential (VHold) through a series of four ramps
(−113 to 87 mV in 2 s) was recorded both under standard
conditions and after [Na+]o had been lowered to 10 mM (N-
methyl-D-glucammonium substitution). The current that
persisted at low [Na+]o was then subtracted from the
corresponding control current in order to isolate the
[Na+]o-dependent component of Im (INa). All reported
potentials are corrected for the liquid junction potential
between the pipette and bath solutions and membrane
potentials (Vm) were inferred from the values of VHold at
which Im was 0. Values of membrane conductance (GNa)
were estimated by regression analysis (i.e., ΔI/ΔVHold).
These methods are described in detail elsewhere [11, 13].
Electrometric studies
H441 cells grown to confluence on Snapwell membranes in
dexamethasone-containing (0.2 μM) medium were
mounted in Ussing chambers and bathed with bicarbon-
ate-buffered physiological salt solution so that short circuit
current (ISC) could be recorded. To assess the Na
+
conductance of the apical membrane GNa(Ap), the salt
solution bathing both sides of the cell layer was replaced
with a “cytoplasm-like” solution containing gluconate as
the principal anion [16]. The basolateral membrane was
then permeabilized (100 μM nystatin) and the increase in
apical membrane current (ΔIAp) evoked by imposing an
inwardly directed [Na+] gradient upon the basolaterally
permeabilized cells was then measured. Since the electro-
chemical driving force for Na+ entry (VNa) is known
(Nernst equation), GNa(Ap) can be determined using the
expression GNa=ΔIAp/VNa. A detailed account of this




Figure 1 shows data from strictly paired experiments that
explored the effects of expressing SGK1-K127A and SGK1-
S422D upon the levels of total and Thr346/456/366-phosphory-
lated NDRG1 in hormone-deprived H441 cells. These studies
show clearly that the NDRG1 protein is expressed by these
cells and it is clear that both groups of cells express very
similar levels of the total NDRG1. However, the Thr346/356/
366-phosphorylated form of NDRG1 was approximately
twofold more abundant in the SGK1-S422D-expressing cells
(Fig. 1b) and, since this SGK1 mutant displays a constitu-
tively active phenotype [25], this result confirms [31] that
increases in cellular SGK1 activity cause increased phosphor-
ylation of NDRG1-Thr346/356/366. Moreover, expression of
SGK1-S422D caused the Thr346/356/366-phosphorylated
NDRG1 to migrate as a doublet band and it is interesting in
this context that the phosphorylation of NDRG1-Thr346/356/366
by SGK1 permits further phosphorylation of this protein by
glycogen synthase kinase 3 (GSK3). This GSK3-mediated
phosphorylation has been shown to affect the protein’s
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electrophoretic mobility and induce the formation of a doublet
band [31].
NDRG1-Thr346/356/366 phosphorylation in unstimulated
cells
Figure 2a (upper panel) shows that the NDRG1 protein is
expressed by untransfected H441 cells maintained in
hormone-deprived medium, and assays using the phospho-
specific antibody [31] revealed phosphorylation of
NDRG1-Thr346/356/366 under these conditions (Fig. 2a).
LY294002 (50 μM), a PI3K inhibitor, essentially abolished
the expression of this phosphoprotein (Fig. 2a) within 1 h
and there was no recovery within 6 h (Fig. 2b). Although
LY294002 also reduced the total abundance of NDRG1,
this effect was relatively small (approximately 25%
reduction), developed slowly (approximately 2 h), and
was not sustained (Fig. 2a,b). It is, therefore, clear that the
LY294002-induced loss of Thr346/356/366-phosphorylated
NDRG1 cannot be attributed to an effect upon overall
expression, and these data, therefore, show that LY294002
causes essentially complete dephosphorylation of NDRG1-
Thr346/356/366 in hormone-deprived cells.
Dexamethasone-induced phosphorylation
of NDRG1-Thr346/356/366
Acute application of dexamethasone (0.2 μM) increased the
abundance of Thr346/356/366-phosphorylated NDRG1 with
no effect upon total expression (Fig. 3a,b), demonstrating
that this synthetic glucocorticoid evokes increased phos-
phorylation of NDRG1-Thr346/356/366. Moreover, in some
experiments, dexamethasone caused the Thr346/356/366-
phosphorylated protein to migrate as a doublet band
(Fig. 3a) although this was not a consistent finding.
Dexamethasone-induced phosphorylation of NDRG1 was
evident after 1 h, peaked after 2–3 h (Fig. 3b), and although
there was some decline from this peak, the abundance of
the Thr346/356/366-phosphorylated protein remained elevated
for 6 h (Fig. 3b). Figure 3c shows the results of experiments
Fig. 1 NDRG1 phosphorylation in SGK1-expressing cells. a Western
blots showing the levels of total and Thr346/356/366-phosphorylated
NDRG1 detected in hormone-deprived cells that had been transfected
with pGL3 plasmids encoding SGK1-K127A or SGK1-S422D. b
Densitometric analysis of the pooled data (mean±SEM) from five such
experiments. All data have been normalized to the mean abundance of
total and SGK1-phosphorylated NDRG1 measured in cells expressing
the catalytically inactive SGK1-K127A mutant. **P<0.02, statistical-
ly significant differences in the expression levels measured in cells
expressing the two forms of SGK1 (Student’s paired t test)
Fig. 2 Phosphorylation of NDRG1-Thr346/356/366 in unstimulated
cells. a Typical Western blots showing the effects of LY294002
(50 μM, 0–6 h) upon the overall expression of NDRG1 protein (upper
panel) and upon the cellular abundance of the Thr346/356/366-
phosphorylated form of this protein (lower panel). b Densitometric
analysis showing the LY294002-induced changes in the cellular
abundance of total and Thr346/356/366-phosphorylated NDRG1. Data
have been normalized to the expression level measured at the onset of
the experiment and are presented as the mean±SEM (n=6). *P<0.05;
***P<0.001; data points that differed significantly from this initial
value
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(n=4) that explored the effects of LY294002 (50 μM, 2 h).
As anticipated (see above), this substance essentially
abolished the phosphorylation of NDRG1-Thr346/356/366 in
unstimulated cells (see Fig. 2) and also blocked the
dexamethasone-induced phosphorylation of these residues.
Figure 4 shows the changes in abundance of total and
Thr346/356/266-phosphorylated NDRG1 induced by long-
term (0–7 days) exposure to dexamethasone. The culture
medium bathing all cells used in these experiments was
changed daily, and control cells were exposed to nominally
hormone-free medium throughout the entire experimental
period, while the experimental cells were exposed to
dexamethasone-supplemented (0.2 μM) medium for the
final 1–7 days. All cells were then lysed and protein was
extracted for Western analysis. This experimental design
ensured that changes in NDRG1 expression cannot be
attributed to variations in the time spent in culture. Visual
examination of these data suggested that prolonged expo-
sure to dexamethasone reduced the overall abundance of
NDRG1 and analysis of variance indicated that the duration
of exposure to this hormone did reduce total NDRG1 levels
(P<0.05). However, analysis of the individual time points
did not confirm this effect, although analysis of the pooled
data derived from cells that had been exposed to dexa-
methasone for 4–7 days did reveal significant inhibition
(26.7±4.4%, P<0.001, Student’s t test). Prolonged expo-
sure to dexamethasone, therefore, causes a slight reduction
in the overall abundance of the NDRG1 protein. However,
prolonged exposure to dexamethasone caused an unambig-
uous fall in the expression of Thr346/356/366-phosphorylated
NDRG1 that developed over 1–3 days (Fig. 4a,b). To
define this effect more fully, the abundance of Thr346/356/
266-phosphorylated NDRG1 was normalized to the total
expression at each time point, and this analysis showed that
NDRG1-Thr346/356/366 phosphorylation fell to approximate-
ly 35% of the control level after 3 days exposure to
dexamethasone. There was no evidence of recovery
(Fig. 4c).
To explore the possibility that the reduced phosphoryla-
tion of NDRG1-Thr346/356/366 seen during prolonged expo-
sure to dexamethasone may reflect increased activity of
phosphoprotein phosphatases, we explored the effects of
okadaic acid, a well-documented inhibitor of such enzymes
[14, 48], upon this component of the response. These
experiments were undertaken using a strictly paired
protocol in which cells were maintained in either hor-
mone-free or dexamethasone-containing medium (0.2 μM)
for 24 h. The experimental cells were exposed to okadaic
acid for the final 4 h of this incubation period while control
cells were exposed to solvent vehicle. Parallel studies of
age-matched cells at identical passage confirmed (Fig. 3)
that brief (2 h) exposure with dexamethasone (0.2 μM)
increased NDRG1-Thr346/356/366 phosphorylation while
data derived from control cells exposed to 0.2 μM
dexamethasone for 24 h verified (Fig. 4) that prolonged
stimulation led to a suppression of NDRG1-Thr346/356/366
phosphorylation. When used at 1 μM, okadaic acid rapidly
and consistently induced cell swelling and the experimental
cells detached from the culture substrate within 20–30 min.
A similar response was usually seen when okadaic acid was
Fig. 3 Acute effects of dexamethasone upon NDRG1-Thr346/356/366
phosphorylation. a Typical Western blots showing the effects of
dexamethasone (0.2 μM) upon the overall abundance of NDRG1 and
the abundance of the Thr346/356/366-phosphorylated protein in cells that
had been maintained in hormone-free medium for 4 days. b
Densitometric analysis showing the effects of dexamethasone upon
the cellular abundance of total and Thr346/356/366-phosphorylated
NDRG1; data are normalized to the level measured at the onset of
each experiment and are presented as the mean±SEM (n=17). *P<
0.05, **P<0.02, ***P<0.01; data points that differed from the initial
values. c Western blot showing the effects of LY294002 (50 μM, 2 h)
upon the cellular abundance of total and Thr346/356/366-phosphorylated
NDRG1 in unstimulated and dexamethasone-stimulated (0.2 μM, 2 h)
cells. Essentially identical data were obtained in four independent
experiments
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used at 0.1 μM but this developed more slowly and, in one
instance, we did isolate protein from cells that had remained
attached to the culture substrate. Analysis of this sample
revealed a striking fall in the overall abundance of NDRG1,
suggesting that 0.1 μM okadaic acid might stimulate NDRG1
degradation. However, when used at 0.01 μM, okadaic acid
had no overt effect upon cell morphology/attachment and
analysis of extracted protein (n=4) showed that this concen-
tration of okadaic acid also had no effect upon the abundance
of either total or Thr346/356/366-phosphorylated NDRG in
control or dexamethasone-treated cells.
Dexamethasone-induced Na+ current
Analysis of the Im–VHold relationship for hormone-
deprived cells (Fig. 5a) showed that Vm was normally
−60.4±3.7 mV and lowering [Na+]o had no effect upon Vm
(Fig. 5a; Vm=−61.0±4.1 mV), indicating that GNa is
negligible under these conditions [see also 11, 13]. Further
analysis confirmed this conclusion by showing that INa
was negligible across the entire range of potentials tested
(Fig. 5b). Parallel studies of age-matched cells that had
been exposed to 0.2 μM dexamethasone for 2–3 h
(Fig. 5c) showed that this hormone depolarized Vm by
approximately 35 mV (Vm=−25.4±2.9 mV; P<0.01) and
lowering [Na+]o consistently hyperpolarized these cells
(−52.3±5.3 mV; P<0.01). Analysis of these data revealed
a dexamethasone-induced, depolarizing Na+ current
(Fig. 5d) and regression analysis showed that GNa (601±
220 pS cell−1) accounted for 33.8±7.0% of the total
membrane conductance at physiologically relevant poten-
tials. The magnitude of this glucocorticoid-induced con-
ductance is, therefore, essentially identical to that
documented in previous studies in which H441 cells were
exposed to dexamethasone for 24–48 h [11, 13] and is,
therefore, clear that the dexamethasone-induced increase
in GNa is fully developed after only 2–3 h. Figure 5e
shows currents recorded from cells that had been stimu-
lated with dexamethasone (0.2 μM, 2–3 h) in the presence
of LY294002 (50 μM). Since the effects of LY294002
upon PI3K are reversible, this compound was present in
all bath solutions used in these experiments. The currents
recorded under these conditions were essentially identical
to those recorded from hormone-deprived cells (Fig. 5e).
Lowering [Na+]o, therefore, had no effect upon Vm
(control: Vm=−60.7±5.2 mV; low Na+: Vm=−62.3±
5.0 mV) and further analysis showed that INa was
negligible (Fig. 5f). LY294002, therefore, abolishes the
dexamethasone-induced increase in GNa.
Figure 6a shows the results of experiments that explored
the effects of heterologously expressing SGK1-K127A
upon the induction of GNa by relatively brief exposure to
dexamethasone (0.2 μM, 2–3 h). Initial studies of cells that
had simply been transfected with GFP showed that the
expression of this fluorescent protein, which served as a
marker of transfection in all such experiments (see the
“Materials and methods” section), had no discernible effect
upon the electrical properties of cells maintained in
nominally hormone-free medium (n=6). Lowering [Na+]o,
therefore, had no effect upon Vm (control=−56.4±3.0 mV;
low Na+=−59.0±3.1 mV) and INa was negligible (Fig. 6a).
Moreover, stimulating such GFP-expressing cells with
dexamethasone (0.2 μM, 2–3 h) caused [Na+]o-dependent
depolarization (control=−35.3±4.6 mV; low Na+=−53.6±
5.6 mV; P<0.05) by inducing a current essentially identical
Fig. 4 Changes in NDRG1 phosphorylation induced by long-term
exposure to dexamethasone. a Typical blots showing the effects of
prolonged exposure to dexamethasone upon the abundance of Thr346/
356/366-phosphorylated NDRG1 and total NDRG1. b Densitometric
analysis showing the effects of dexamethasone upon the abundance of
Thr346/356/366-NDRG1 phosphorylated and total NDRG1. c Effects of
dexamethasone upon the relative phosphorylation of NDRG1 which
was determined by normalizing the abundance of the Thr346/356/366-
phosphorylated protein to the overall abundance measured at each
time point. All data are presented as the mean±SEM. *P<0.05, **P<
0.02, ***P<0.01; statistically significant variations from the data
derived from the cells that were maintained in hormone-free medium
for the entire experimental period (analysis of variance/Bonferroni
post hoc test)
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to that seen in untransfected cells (Fig. 6a). It is, therefore, clear
that exposure to transfection reagents/expression of heterolo-
gous protein does not affect the induction of this current.
Analysis of currents recorded from SGK1-K127A-expressing
cells that had been stimulated with dexamethasone (0.2 μM,
2–3 h) showed that expression of this catalytically inactive
SGK1 mutant had no effect upon Vm (−39.6±4.3 mV) and did
not affect the hyperpolarization induced by lowering [Na+]o
(SGK1-K127A: ΔVm=−21.3±2.9 mV; GFP alone ΔVm=
−18.3±5.3 mV) and further analysis showed that this mutant
form of SGK1 had no effect upon the dexamethasone-induced
INa (Fig. 6a). It is, therefore, clear that heterologous expression
of SGK1-K127A does not disrupt the dexamethasone-
mediated control of GNa.
Figure 6b shows the results of experiments that explored
the effects of this mutant protein upon the ability of
dexamethasone (0.2 μM, 2 h) to induce the phosphorylation
of NDRG1-Thr346/356/366. Studies of cells that had simply
been transfected with the empty pGL3 plasmid confirmed
that this hormone normally stimulates the phosphorylation of
these residues (Fig. 6b). Although SGK1-K127A had no
statistically significant effect upon the phosphorylation of
NDRG1-Thr346/356/366 in unstimulated cells, this mutant
protein did appear to cause a slight increase the phosphor-
ylation of these residues in some experiments (see Fig. 6b).
However, the most important result to emerge from these
studies was that dexamethasone-consistently failed to evoke
any further phosphorylation of NDRG1-Thr346/356/366 in the
SGK1-K127A-expressing cells (Fig. 6b). This catalytically
inactive form of SGK1, therefore, suppresses this component
of the response to dexamethasone without affecting the
induction of GNa (Fig. 6a) and this discrepancy suggests that
SGK1 may not be important to the dexamethasone-mediated
control of GNa. This series of experiments also confirmed
(see Fig. 1) that SGK1-S422D consistently increased the
phosphorylation of NDRG1-Thr346/356/366 in hormone-
deprived cells and established that dexamethasone has no
additional effect these conditions (Fig. 6b).
Forskolin-evoked Na+ transport in confluent cells
As anticipated by earlier work [27, 37, 49], H441 cells
cultured on permeable supports and maintained (7 days) in
dexamethasone-containing medium became incorporated
into electrically resistive epithelial sheets and generated
amiloride-sensitive ISC due to electrogenic Na
+ absorption.
Figure 7a shows that LY294002 (50 μM) caused substantial
(approximately 60%) inhibition of this dexamethasone-
induced [see, e.g., 37] current [see also 49]. This effect
became apparent as soon as the cells were exposed to the
Fig. 5 Dexamethasone-induced Na currents. a, c, and e each show the
relationships between membrane current (Im, mean±SEM) and holding
potential (VHold) and each figure includes data recorded during
exposure to the standard bath solution (Control) and 20–30 s after
[Na+]o had been lowered to 10 mM (Low Na
+). The results of each
such experiment were further analyzed by digitally subtracting the
current that persisted at low Na+ from the corresponding record of
control current in order to isolate the [Na+]o-dependent component of
the total membrane current (IN), and the results of this analysis are
presented (mean±SEM) in b, d, and f. Data were derived from
hormone-deprived cells (a and b, n=7); cells stimulated with 0.2 μM
dexamethasone for 2–3 h (c and d, n=10), and from cells stimulated
with 0.2 μM dexamethasone (2–3 h) in the presence of 50 μM
LY294002 (e and f, n=6)
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drug but developed relatively slowly (20–30 min; Fig. 7a).
Once this inhibitory action was fully developed, the cells
were basolaterally permeabilized so that GNa(Ap) could be
measured (see the “Materials and methods” section) and the
results of this analysis are shown in Fig. 7b together with
data from age-matched cells that had not been exposed to
LY294002 but which had otherwise been treated identical-
ly. These data show that the LY294002-induced fall in ISC
was associated with a clear reduction in GNa(Ap) (Fig. 7b).
Figure 7a also shows that forskolin, a diterpene that evokes
cAMP formation [42], increased the ISC recorded from
dexamethasone-stimulated cells and studies of basolaterally
permeabilized cells confirmed [37] that this response is
associated with a rise in GNa (Fig. 7b). Moreover, forskolin
consistently increased ISC (Fig. 7a) and GNa(Ap) (Fig. 7b) in
LY294002-treated cells and so, although this inhibitor of
PI3K inhibits the dexamethasone-induced ISC, it does not
block the electrometric response to forskolin [see also 49].
Forskolin-induced phosphorylation of CREB-Ser133
and NDRG1-Thr346/356/366
Analyses of protein extracted from cells grown to conflu-
ence in dexamethasone-containing medium (8 days)
showed that forskolin (10 μM, 20 min) evoked phosphor-
ylation of CREB-Ser133, and this response, which is
consistent with increased activity of protein kinase A
(PKA) [42], persisted in LY294002-treated cells (Fig. 7c,d).
Visual examination of these data suggested that LY294002
might slightly increase the phosphorylation of CREB-Ser133
(Fig. 7c,d) but this effect was not statistical significant in this
series of experiments (Fig. 7d). However, analysis of the
pooled data from all experiments in which we monitored the
phosphorylation of CREB-Ser133 in the presence of
LY294002 (i.e., including the data shown in Fig. 8) showed
that this PI3K inhibitor did evoke a small increase (21.7±
6.4% stimulation, P<0.05) in CREB-Ser133 phosphorylation.
This suggest that PI3K-dependent and cAMP-dependent
signaling pathways may interact, but the physiological basis
of this effect was not investigated further in the present
study. Although prolonged stimulation with dexamethasone
reduced the phosphorylation of NDRG1-Thr346/356/366, anal-
ysis of protein extracted from cells that had been chronically
exposed to this hormone could still provide a clear signal on
a Western blot if the amount of protein loaded onto the gels
was increased (25 μg) and if the exposure time was
extended. Such analyses showed that LY294002 essentially
abolished the residual phosphorylation of NDRG1-Thr346/
356/366 that persisted under these conditions, and established
forskolin had no discernible effect upon the phosphorylation
of NDRG1-Thr346/356/366 in either control or LY294002-
treated cells (Fig. 7e,f). The electrometric response to
forskolin, therefore, occurs with no change in SGK1 activity.
Insulin-induced Na+ transport in confluent cells
It is well-established that insulin stimulates Na+ transport in
the epithelia of the distal nephron [see, e.g., 5, 7] and this
hormone has recently been shown to augment the dexa-
methasone-induced GNa in H441 cells [11]. The present
study, therefore, explored the effects of insulin upon the ISC
generated by H441 cells grown to confluence in dexameth-
asone-containing medium. Figure 8a shows that this
hormone (20 nM) acutely increased the ISC recorded under
these conditions and, although this response was preceded
by a transient fall in ISC, it was generally similar to the
response to forskolin (see Fig. 7a). Studies of basolaterally
permeabilized cells showed that this response to insulin was
associated with a rise in GNa(Ap) (Fig. 8b), and it is,
Fig. 6 Effects of SGK1-K127A upon the dexamethasone-induced INa
and phosphorylation of NDRG1-Thr346/356/366. a In each experiment,
Im was recorded both under standard conditions and after [Na
+]o had
been lowered to 10 mM and these data were then analyzed in order to
isolate INa which has been plotted (mean±SEM) against VHold. i Data
derived from GFP-expressing cells maintained in nominally hormone-
free medium (n=6). ii Data from GFP-expressing cells exposed to
0.2 μM dexamethasone for 2–3 h (n=6). iii Data from cells expressing
GFP/SGK1-K127A that had been exposed to 0.2 μM dexamethasone
for 2–3 h (n=6). b Typical blots showing the effects of dexamethasone
(0.2 μM, 2 h) upon the abundance of Thr346/356/366-phosphorylated
and total NDRG1 in cells that had simply been transfected with the
empty pGL3 plasmid (Cont.) and in cells expressing SGK1-K127A or
SGK1-S422D. Essentially identical; results were obtained in five
independent experiments
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therefore, clear that insulin and forskolin can both acutely
regulate the dexamethasone-induced apical Na+ conduc-
tance in H441 cells. Figure 8a includes data from age-
matched cells at identical passage that had been exposed to
LY294002. These data confirm that this PI3K inhibitor
reduces the basal (i.e., dexamethasone-induced) ISC but also
show that insulin cannot increase ISC (Fig. 8a) or GNa(Ap)
(Fig. 8b) in LY294002-treated cells. The electrometric
response to insulin, in contrast to the response to forskolin,
is, therefore, abolished by LY294002.
Insulin-induced phosphorylation of CREB-Ser133
and NDRG1-Thr346/356/366
Analyses of protein extracted from dexamethasone-treated
cells (0.2 μM, 7 days) showed that insulin (20 nM, 30 min)
had no effect upon the phosphorylation of CREB-Ser133 in
either control or LY294002-treated cells (Fig. 8c,d), and
this finding is, therefore, consistent with a body of data
which show that this hormone does not signal via cAMP/
PKA [15]. However, insulin (20 nM, 30 min) normally
increased the phosphorylation of NDRG1-Thr346/356/366 and
this response, in common with the stimulation of Na+
transport, was abolished by LY294002 (Fig. 8e,f).
Discussion
NDRG1-Thr346/356/366 phosphorylation as an SGK1 assay
While the hormonally induced SGK1 expression can be
quantified by Western analysis of extracted protein, this
Fig. 7 The response to forsko-
lin in confluent cells. a Results
of electrometric experiments
(n=6) showing the effects of
forskolin (10 μM, added as
indicated by the shaded box)
upon the ISC generated and
LY294002-treated cells
(50 μM, added as indicated by
the arrow). Control cells were
exposed to solvent vehicle. b
Effects of forskolin upon GNa in
control and LY294002-treated
cells. Shaded bars show data
from forskolin-stimulated cells
while open bars show data from
unstimulated, age-matched cells
at identical passage. c Typical
Western blots showing the effects
of forskolin and LY294002 upon
the total abundance of CREB
(upper panel) and the abundance
of phosphorylated CREB (lower
panel). d Densitometric analysis
showing the pooled results of
five independent experiments. e
Typical Western blots showing
the effects of forskolin and/or
LY294002 upon the overall
abundance of NDRG-1 (upper
panel) and the abundance of
phosphorylated NDRG-1 (lower
panel). f Densitometric analysis
showing the pooled data from
five independent experiments.
All values are presented as the
mean±SEM. **P<0.02, ***P<
0.01, statistically significant
effects of forskolin; †P<0.05,
statistically significant effects of
LY294002 (Student’s paired
t test)
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approach is complicated by the fact that SGK1 is expressed
at very low levels in many cell types, implying that large
amounts of protein are needed to obtain meaningful signals.
Demonstration of dexamethasone-induced SGK1 expres-
sion in A6 cells [51] thus required the fractionation of
105 μg aliquots of cellular protein while some of the
analyses presented in an earlier study of H441 cells [49]
involved the fractionation of 400 μg protein aliquots.
Moreover, although the activation of SGK1 has been
studied using phosphospecific antibodies to monitor the
phosphorylation of specific residues within this protein, this
approach has usually been used to study the control of
heterologously expressed SGK1 [e.g., 21]. When used to
assess the phosphorylation of endogenous SGK1, these
antibodies almost invariably stain multiple bands which
makes the results of such studies hard to interpret [for
example, see Fig. 9 in ref. 31].
There is, therefore, a need for a simple and relatively
sensitivemethod of assaying cellular SGK1 activity and studies
of HeLa cells and SGK1 knockout mice showed that the
phosphorylation of NDRG1-Thr346/356/366 can provide a read
out of the activity of this kinase [31]. These studies showed
clearly that the phosphorylation of NDRG1-Thr346/356/366 is
entirely dependent upon the expression of SGK1 [31] and
stimuli that characteristically activate SGK1 (exposure to
serum, stimulation with insulin-like growth factor 1) thus
have no effect upon the phosphorylation of these residues if
cellular SGK1 expression is abolished using short interfering
RNAs. However, such knockdown of SGK1 has no effect
upon the activation of PKB, a closely related kinase that is
Fig. 8 The response to insulin
in confluent cells. a Effects of
insulin (20 nM, n=7, added as
indicated by the shaded box)
upon the ISC generated by con-
trol (i.e. solvent vehicle) and
LY294002-treated (50 μM,
added as indicated by the arrow)
cells. b Effects of insulin upon
GNa in control and LY294002-
treated cells. Shaded bars show
data from insulin-stimulated
cells while open bars show data
from unstimulated, age-matched
cells at identical passage. c
Typical Western blots showing
the effects of insulin and/or
LY294002 upon the overall
abundance of CREB (upper
panel) and the abundance of
phosphorylated CREB (lower
panel). d Densitometric analysis
of the pooled data from six
independent experiments. e
Typical Western blots showing
the effects of insulin and/or
LY294002 upon the overall
abundance of NDRG-1 (upper
panel) and the abundance of
Thr346/356/366-phosphorylated
NDRG-1 (lower panel). f Den-
sitometric analysis showing the
pooled data from five indepen-
dent experiments. All data are
presented as the mean±SEM.
**P<0.02, ***P<0.01, statisti-
cally significant effects of insu-
lin; †P<0.05, statistically
significant effects of LY294002
(Student’s paired t test)
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often activated in parallel with SGK1 [15]. While these data
show that NDRG1-Thr346/356/366 is phosphorylated by SGK1
but not by other related kinases [31, 32], the functional
significance of this phosphorylation is unknown. As far as we
are aware, there is no evidence that NDRG1 mediates any
SGK1-dependent response, although a recent study has
provided very strong evidence to suggest that the closely
related NDRG2 protein, which is also phosphorylated by
SGK1 [31], may be directly involved in the hormonal
stimulation of epithelial Na+ channel function [52].
The fact that NDRG1-Thr346/356/366 phosphorylation is
so strictly dependent upon SGK1 suggested that changes
in cellular SGK1 activity might be monitored by assaying
the phosphorylation status of these residues. The present
data further support this hypothesis by showing that
transfection with a plasmid encoding SGK1-S422D, an
SGK1 mutant that displays an active phenotype [25],
increased the phosphorylation of NDRG1-Thr346/356/366 to
a level approximately twofold above that measured in
cells expressing a catalytically inactive, control construct
(SGK1-K127A). Moreover, analysis of protein extracted
from hormone-deprived cells showed that the basal
phosphorylation of NDRG1-Thr346/356/366 was abolished
by LY294002, an inhibitor of PI3K [see also 31]. This
provides further support for the view that NDRG1-Thr346/
356/366 phosphorylation can indicate cellular SGK1 activity
since the activity of SGK1 is maintained by PI3K, which
controls the phosphorylation of SGK1-Ser422 and SGK1-
Ser256 by PDK2 and PDK1, respectively [25, 34]. It thus
appears that this new method [31] may provide a relatively
simple way of monitoring the activity of SGK1 in Na+-
absorbing epithelia, and the present study, therefore, used
this new approach to explore the role of SGK1 in the
induction/regulation of the glucocorticoid-dependent GNa
in H441 human airway epithelial cells [11, 13, 37].
Dexamethasone-induced activation of SGK1
Acute exposure to dexamethasone evoked phosphorylation
of NDRG1-Thr346/356/366, indicating increased SGK1 activ-
ity, and this finding accords with the well-documented
properties of this kinase [26] and with data from earlier
studies of Na+-absorbing epithelia which showed that
dexamethasone increases the expression of SGK1 mRNA
and protein [24, 49, 51]. The relative sensitivity of the
assay used in this study [31] allowed us to show that the
activation of SGK1 is apparent after approximately 1 h and
peaks at 2–3 h. Moreover, this response was abolished by
LY294002, indicating a requirement for PI3K [see also 25,
34], and it is, therefore, interesting to note that earlier
studies of A6 cells showed that LY294002 does not block
steroid-induced synthesis of SGK but does abolish the
subsequent phosphorylation of this protein [34, 51].
We also explored the changes in SGK1 activity evoked
by prolonged exposure to dexamethasone and these data
suggested that the increased activity of this enzyme is not
sustained since, after 3 days, the phosphorylation of
NDRG1-Thr346/356/366 had fallen to approximately 30% of
the level measured in hormone-deprived cells. Although the
earlier assays of SGK1 mRNA and protein levels similarly
suggested that dexamethasone-induced SGK1 activation
might not be well-maintained [24, 49, 51], the present data
were still surprising since we can routinely record dexa-
methasone-induced Na+ currents from H441 cells that have
been exposed to this hormone for 24–48 h [11, 13], and the
present data suggest that SGK1 activity may actually be
reduced by this time. Moreover, cells grown to confluence
in dexamethasone-containing medium for 6–8 days consis-
tently generate ISC due to the expression of a glucocorti-
coid-induced apical Na+ conductance [27, 37] and the
present data suggest that this dexamethasone-induced
absorption of Na+ in H441 cells may persist despite a loss
of cellular SGK1 activity.
We explored the possibility that this loss of NDRG1
phosphorylation may reflect increased activity of phospho-
protein phosphatases (PP1, PP2A, etc.) by studying the
effect of okadaic acid, a substance that inhibits such
enzymes [14, 48]. However, the interpretation of these
experiments was complicated by the fact that the cells did
not tolerate okadaic acid at concentrations high enough to
achieve unambiguous inhibition of phosphoprotein phos-
phatase activity. However, the dexamethasone-induced loss
of NDRG1-Thr346/356/366 phosphorylation was not reversed
by 0.01 μM okadaic acid and this concentration is high
enough to cause essentially complete inhibition of PP2A
and PP4 and to substantially reduce the activity of PP5 [14,
48]. While these enzymes do not appear to mediate the
dephosphorylation of NDRG1 during prolonged exposure
to dexamethasone, we cannot exclude the possibility that
enzymes such as PP1 and PP2B may underlie the
dephosphorylation of NDRG1-Thr346/356/366 that develops
during prolonged exposure to dexamethasone [14, 48].
Dexamethasone-induced INa
While stimulation with dexamethasone depolarizes
hormone-deprived H441 cells by increasing GNa [11, 13],
the signaling pathways underlying this response are not
well-defined. However, studies of other Na+-absorbing
epithelia have shown that GNa is normally restricted by
the continual removal of Na+ channels from the plasma
membrane and this channel internalization process seems to
be mediated by Nedd-4/2, a ubiquitin ligase which binds to
Na+ channels in the plasma membrane and targets them for
ubiquitination, internalization, and degradation [17, 44, 47].
In this context, it is relevant that SGK1 can block this
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interaction between Nedd-4/2 and the epithelial Na+
channel by phosphorylating Nedd-4/2 at Ser221, Thr246,
and Ser327. This allows SGK1 to control GNa by regulating
Na+ channel internalization, and heterologous expression of
active SGK1, therefore, mimics the effects of steroid
stimulation by activating the endogenous Na+ conductance
in A6 cells and in H441 cells [1, 11, 19] and also enhances
INa in Xenopus oocytes and fisher rat thyroid cells
expressing the component subunits of the epithelial Na+
channel [12, 29, 33, 45]. However, it is interesting to note
that Nedd-4/2 also mediates the ubiquitination/degradation
of SGK1 itself and, although the SGK1-mediated phos-
phorylation of Nedd-4/2 blocks the interaction with the
epithelial Na+ channel, this phosphorylation does appear to
facilitate an interaction between Nedd-4/2 and SGK1 [56].
This mechanism, therefore, allows SGK1 to control its own
degradation [56] and this negative feedback phenomenon
could contribute to the apparent loss of SGK1 activity seen
during prolonged exposure to dexamethasone (Fig. 4).
The fact that SGK1 can influence Na+ channel internal-
ization/degradation suggested that the activation of SGK1
by steroid hormones can explain the associated rise in GNa,
and the present data support this hypothesis by showing
that the dexamethasone-induced rise in GNa coincides with
the activation of SGK1. Moreover, the rise in GNa and the
activation of SGK1 are both abolished by LY294002 and
this accords well with earlier data from A6 cells which
showed that inhibition of PI3K blocks aldosterone-induced
Na+ transport by reducing the number of active Na+
channels in the apical membrane [6, 35]. It is interesting
to note in this context that, as well as phosphorylating
Nedd-4/2, SGK1 has also been shown to evoke increased
epithelial Na+ channel activity by a separate mechanism
dependent upon the phosphorylation of a residue (Ser621)
within an SGK1 consensus sequence in the channel’s α-
subunit [18].
However, not all of our data were consistent with the
idea that SGK1 played such a central role in the control of
GNa since the expression of a catalytically inactive SGK1
mutant (SGK1-K127A) that has been shown to exert a
dominant negative effect in Xenopus oocyte expression
systems [29] did not affect the induction of GNa by
dexamethasone and, while this result was initially surpris-
ing, it does agree with earlier data from A6 cells. Moreover,
the expression of SGK1-K127A expression did suppress
the dexamethasone-induced phosphorylation of NDRG1-
Thr346/356/366, suggesting that this mutant protein does
suppress the hormonally induced activation of SGK1. The
present data also show hormone-deprived H441 display
basal SGK1 activity despite the fact that GNa is negligible
[present study, 11, 13] and, taken together, these observa-
tions provide evidence against the idea that SGK1 allows
dexamethasone to control Na+ transport. It is important to
remember that SGK1 is not the only steroid-inducible gene
involved in the control of GNa since glucocorticoids also
regulate the transcription of genes encoding the epithelial
Na+ channel subunits [10, 41] and induce expression of a
protein known as glucocorticoid-inducible leucine zipper
protein that suppresses signaling via the extracellular
signal-regulated kinase (ERK)-dependent pathway [4]. This
latter action could be highly significant since the activation
of ERK is known to inhibit epithelial channel expression
and function [8, 28, 43, 54, 55].
Regulation of Na+ transport in confluent cells
The present data confirm that H441 cells grown to
confluence on permeable supports in dexamethasone-
containing medium become incorporated into electrically
resistive epithelial sheets that absorb Na+ from the apical
bath [see 27, 37, 49]. Although prolonged exposure to
dexamethasone caused a fall in NDRG1-Thr346/356/366
phosphorylation (see above), LY294002 virtually abolished
the residual phosphorylation, indicating almost total inac-
tivation of SGK1. LY294002 also reduced ISC and GNa(Ap),
and these findings are consistent with the view that PI3K is
important to the maintenance of cellular SGK1 activity [25,
34] and to steroid-induced Na+ transport [6, 49]. The
studies also confirm [27, 37, 49] that forskolin stimulates
transepithelial Na+ transport and extend upon these earlier
findings by showing that insulin induces a similar response.
Both responses involved increases in GNa(Ap) and, as far as
we are aware, these data provide the first demonstration that
insulin can control transepithelial Na+ transport in H441
cells although this is well-documented in renal epithelia
[e.g., 1, 38].
Forskolin characteristically evokes signaling via cAMP/
PKA [42], and studies of granulosa cells [20] and COS-7
cells [36] suggest that the activation of this signaling
pathway may lead to increased activity of SGK1. More-
over, forskolin has been reported to increase the phosphor-
ylation of SGK1 in H441 cells and it was, therefore,
suggested that cAMP/PKA-induced Na+ transport might
involve increased activity of SGK1 [36, 49]. However, the
apparent effect of forskolin upon SGK1 phosphorylation
developed rather slowly, becoming evident after approxi-
mately 15 min and increasing progressively over the
following 45 min [49] while forskolin-evoked Na+ transport
is a much more rapid response that is evident after only 3–
5 min [see, e.g., present study, 49]. Moreover, the present
data show that forskolin-evoked Na+ transport was not
associated with any change to the phosphorylation status of
NDRG1-Thr346/356/366 and also established that this re-
sponse persists in LY294002-treated cells despite essential-
ly complete loss of SGK1 activity/NDRG1-Thr346/356/366
phosphorylation. The response to forskolin was, however,
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associated with increased phosphorylation of CREB-Ser133
and, since the phosphorylation of this residue indicates
PKA activity, our data suggest that the activation of the
cAMP/PKA-evoked Na+ transport occurs independently of
any change in SGK1 activity. Insulin-evoked Na+ transport,
on the other hand, was associated with increased phosphor-
ylation of NDRG1-Thr346/356/366 and was very effectively
abolished by LY294002. These data accord well with the
idea that insulin characteristically activates SGK1 [15], and
it is, therefore, interesting to note that studies of renal
epithelia have also implicated SGK1 in the control of
insulin-evoked Na+ transport [see, e.g., 5, 7, 38]. Indeed,
genetic variance in the sgk1 gene is associated with insulin-
dependent hypertension that appears to be secondary to
increased Na+ transport in the aldosterone-sensitive epithe-
lia of the distal nephron [22, 23, 50].
Although the electrophysiological responses to forskolin
and insulin are superficially similar, it thus appears that the
response to insulin is mediated via SGK1 while the
response to forskolin is not [see also 5, 7, 38]. It is,
therefore, interesting to note that PKA and SGK1 have
recently been shown to phosphorylate the same residues on
Nedd-4/2, suggesting that this ubiquitin ligase may form an
important convergence point between the SGK1-dependent
and PKA-dependent signaling pathways [46].
Significance of present findings
The present data, therefore, show that the dexametha-
sone-induced activation of SGK1 coincides with the
increase in GNa and demonstrate that both responses are
dependent upon PI3K. While these data suggest that
SGK1 might allow steroid hormones to regulate Na+
absorption, we also show (1) that hormone-deprived cells
display significant SGK1 activity despite the fact that GNa
is negligible, (2) that chronic exposure to dexamethasone
causes an apparent loss of SGK1 activity even though Na+
transport is well-maintained [11, 27, 37], and (3) that a
catalytically inactive SGK1 mutant does not impair the
dexamethasone-induced rise in GNa but does appear to
suppress the activation of SGK1. Taken together, these
data suggest that the SGK1 may play a minor role in the
control of Na+ transport by steroid hormones [see also 1,
2] which may explain why sgk1 knockout has variable
effects in different tissues [39, 53].
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